Related Experiment Video

Updated: Jul 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[On the use of statins in patients with chronic cardiac insufficiency]

L I Ol'binskaia, Zh M Sizova, V L Zakharova

    Klinicheskaia Meditsina
    |November 28, 2007
    PubMed

    Insights

    Statins are vital for preventing coronary artery disease (CAD). For chronic cardiac insufficiency (CCI) patients, statin therapy showed no worsening of symptoms but requires individualized approach based on lipid levels and disease severity.

    Area of Science:

    • Cardiology
    • Pharmacology

    Context:

    • Coronary artery disease (CAD) necessitates hypolipidemic agents like statins for prevention.
    • The role of statins in chronic cardiac insufficiency (CCI) patients remains under investigation due to limited data on prognostic improvement.

    Purpose:

    • To investigate the long-term effects of statins combined with standard therapy in patients with CCI complicating CAD.
    • To assess the correlation between lipid profiles and CCI severity.
    • To evaluate the safety and efficacy of hypolipidemic therapy in CCI patients.

    Summary:

    • A long-term study involving CCI patients with CAD demonstrated a reverse correlation between total cholesterol, low-density lipoprotein cholesterol, and CCI severity.
    • Continuous statin therapy in combination with other medications did not exacerbate clinical symptoms in CCI patients.
    • Hypolipidemic therapy in CCI patients necessitates a differentiated approach, considering baseline lipid profiles and disease severity.

    Impact:

    • Findings suggest that statins can be safely used in CCI patients with CAD, without worsening clinical status.
    • Highlights the importance of personalized lipid-lowering treatment strategies for this patient group.
    • Contributes to the ongoing discussion regarding the benefits of statins in complex cardiac conditions.

    Related Concept Videos

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...